
The Washington Post @washingtonpost
The federal government has resumed shipping all three monoclonal antibody treatments authorized for early-stage covid-19 to states despite evidence that two might be ineffective against the omicron variant of the coronavirus that is sweeping the country. https://t.co/7r7Ain1cfD — PolitiTweet.org